Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02742090
Title Evaluate the Efficacy and Safety of TGR-1202 in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors TG Therapeutics, Inc.
Indications

chronic lymphocytic leukemia

Therapies

Umbralisib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
TG Therapeutics Investigational Trial Site Huntsville Alabama 35805 United States Details
TG Therapeutics Investigational Trial Site Washington District of Columbia 20007 United States Details
TG Therapeutics Investigational Trial Site Fort Myers Florida 33916 United States Details
TG Therapeutics Investigational Trial Site Saint Petersburg Florida 33705 United States Details
TG Therapeutics Investigational Trial Site Kansas City Missouri 64132 United States Details
TG Therapeutics Investigational Trial Site Lebanon New Hampshire 03756 United States Details
TG Therapeutics Investigational Trial Site Hackensack New Jersey 07601 United States Details
TG Therapeutics Investigational Trial Site New Hyde Park New York 11042 United States Details
TG Therapeutics Investigational Trial Site New York New York 10032 United States Details
TG Therapeutics Investigational Trial Site Rochester New York 14642 United States Details
TG Therapeutics Investigational Trial Site Durham North Carolina 27710 United States Details
TG Therapeutics Investigational Trial Site Hershey Pennsylvania 17033 United States Details
TG Therapeutics Investigational Trial Site Philadelphia Pennsylvania 19146 United States Details
TG Therapeutics Investigational Trial Site Nashville Tennessee 37203 United States Details
TG Therapeutics Investigational Trial Site Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field